Business Context and Reporting Period
This Form 8-K is a current report filed by WellPoint, Inc. (now Elevance Health, Inc.) on March 12, 2013. The filing serves as a Regulation FD disclosure regarding upcoming communications between company officers and securities analysts/investors scheduled between March 12, 2013, and March 29, 2013.
Key Financial Metrics
The filing does not provide historical financial data such as revenue, profit, cash flow, margins, debt, or liquidity for the current or prior periods. The only specific financial metric disclosed is forward-looking guidance.
- 2013 Full-Year EPS Guidance: At least $7.60 per share.
- Guidance Scope: Includes integration costs related to the Amerigroup acquisition.
Material Changes
The filing does not report material changes to financial results or operations compared to prior periods. It solely announces the reaffirmation of existing full-year 2013 earnings guidance.
Guidance, Outlook, and Risks
Management Commentary and Outlook: Officers expect to reaffirm the net income per share guidance of at least $7.60 for the full year 2013 during analyst meetings. This guidance explicitly accounts for integration costs associated with the Amerigroup acquisition.
Risks and Contingencies: The filing includes a comprehensive Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. Key risks identified include:
- Impact of the Patient Protection and Affordable Care Act and related regulations.
- Trends in health care costs, utilization rates, and premium rate approvals.
- Integration challenges with Amerigroup and 1-800 CONTACTS, Inc., including potential delays, higher costs, or lower revenues than expected.
- Risks related to Medicare and Medicaid programs, including funding and compliance.
- Financial strength rating downgrades and litigation risks.
- Compliance with the Express Scripts, Inc. pharmacy benefit management agreement.
- Information system failures and data security breaches.
- General economic downturns and investment portfolio risks.
Investor Verification Checklist
- Verify the actual full-year 2013 earnings per share against the $7.60 guidance.
- Monitor the progress and cost of the Amerigroup acquisition integration.
- Review subsequent filings for updates on regulatory impacts from the Affordable Care Act.
- Check for any changes in financial strength ratings or litigation outcomes.
- Confirm the status of the Express Scripts, Inc. agreement compliance.